Cargando…

Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection

Background There is ample literature describing surgical outcomes after oncologic musculoskeletal tumor surgery, however, there is limited understanding of the time to optimization of functional outcome scores after resection. The purpose of this study was to identify the time to functional outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Westlake, Babe, Pipitone, Olivia, Tedesco, Nicholas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411075/
https://www.ncbi.nlm.nih.gov/pubmed/36043020
http://dx.doi.org/10.7759/cureus.27317
_version_ 1784775238963167232
author Westlake, Babe
Pipitone, Olivia
Tedesco, Nicholas S
author_facet Westlake, Babe
Pipitone, Olivia
Tedesco, Nicholas S
author_sort Westlake, Babe
collection PubMed
description Background There is ample literature describing surgical outcomes after oncologic musculoskeletal tumor surgery, however, there is limited understanding of the time to optimization of functional outcome scores after resection. The purpose of this study was to identify the time to functional outcome optimization of Musculoskeletal Tumor Society (MSTS) scores after surgery for bone and soft tissue tumors and to identify factors correlated with recovery. Methods We retrospectively reviewed 187 patients from April 2016 to May 2021 that had undergone surgical treatment for musculoskeletal tumors. We assessed MSTS scores to determine the time to optimization and evaluated patient-specific and surgical factors for any influence on post-operative recovery. Results The majority of patients (92%) achieved their optimized score in one year or less. Eighty-two percent achieved the maximum MSTS score of 30. Osseous tumors, malignancy, adjuvant treatment with radiation and/or chemotherapy, deep location for soft tissue tumors, and bony work required for soft tissue tumors all significantly impacted time to MSTS score optimization. Conclusion The majority of patients with musculoskeletal tumors undergoing surgery can be expected to improve up to one year postoperatively. Those with bone tumors, malignant tumors, treatment with radiation and/or chemotherapy, deep soft tissue tumors, and bony work for soft tissue tumors can expect to have a longer recovery time and are at higher risk for not achieving premorbid functionality.
format Online
Article
Text
id pubmed-9411075
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94110752022-08-29 Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection Westlake, Babe Pipitone, Olivia Tedesco, Nicholas S Cureus Oncology Background There is ample literature describing surgical outcomes after oncologic musculoskeletal tumor surgery, however, there is limited understanding of the time to optimization of functional outcome scores after resection. The purpose of this study was to identify the time to functional outcome optimization of Musculoskeletal Tumor Society (MSTS) scores after surgery for bone and soft tissue tumors and to identify factors correlated with recovery. Methods We retrospectively reviewed 187 patients from April 2016 to May 2021 that had undergone surgical treatment for musculoskeletal tumors. We assessed MSTS scores to determine the time to optimization and evaluated patient-specific and surgical factors for any influence on post-operative recovery. Results The majority of patients (92%) achieved their optimized score in one year or less. Eighty-two percent achieved the maximum MSTS score of 30. Osseous tumors, malignancy, adjuvant treatment with radiation and/or chemotherapy, deep location for soft tissue tumors, and bony work required for soft tissue tumors all significantly impacted time to MSTS score optimization. Conclusion The majority of patients with musculoskeletal tumors undergoing surgery can be expected to improve up to one year postoperatively. Those with bone tumors, malignant tumors, treatment with radiation and/or chemotherapy, deep soft tissue tumors, and bony work for soft tissue tumors can expect to have a longer recovery time and are at higher risk for not achieving premorbid functionality. Cureus 2022-07-26 /pmc/articles/PMC9411075/ /pubmed/36043020 http://dx.doi.org/10.7759/cureus.27317 Text en Copyright © 2022, Westlake et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Westlake, Babe
Pipitone, Olivia
Tedesco, Nicholas S
Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title_full Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title_fullStr Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title_full_unstemmed Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title_short Time to Functional Outcome Optimization After Musculoskeletal Tumor Resection
title_sort time to functional outcome optimization after musculoskeletal tumor resection
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411075/
https://www.ncbi.nlm.nih.gov/pubmed/36043020
http://dx.doi.org/10.7759/cureus.27317
work_keys_str_mv AT westlakebabe timetofunctionaloutcomeoptimizationaftermusculoskeletaltumorresection
AT pipitoneolivia timetofunctionaloutcomeoptimizationaftermusculoskeletaltumorresection
AT tedesconicholass timetofunctionaloutcomeoptimizationaftermusculoskeletaltumorresection